Tempus

Director of Business Intelligence

Chicago, Illinois, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Data Science, Artificial IntelligenceIndustries

Requirements

Candidates should possess a Bachelor’s degree in Information Systems, Business Administration, Finance, Economics, Mathematics, Operations Research, Marketing, or a related field, and a Master’s degree is preferred. They must have 10+ years of experience in business intelligence or data analytics, with at least 5 years in a leadership role, and a proven track record of managing BI teams and delivering complex analytics projects. Strong technical proficiency in BI tools such as Looker and data warehousing solutions like BigQuery, along with advanced SQL skills and a deep understanding of database modeling concepts, is required.

Responsibilities

The Director of Business Intelligence will lead and manage a team of approximately 12 Business Intelligence (BI) professionals, fostering a culture of innovation and continuous improvement, and ensuring their work aligns with critical business initiatives. They will partner with cross-functional teams to identify BI needs and provide guidance and analytical support for developing new datasets and tools. The Director will also understand the complex business environment of Tempus AI, intersecting healthcare, genomics, and data science, and ensure BI initiatives align with the functions and needs of various departments. Furthermore, they will ensure adherence to data governance policies, support data management best practices, and stay abreast of emerging BI technologies, particularly in AI-driven analytics, to integrate AI tools and enhance productivity.

Skills

Business Intelligence
Data Analysis
Team Leadership
Stakeholder Management
Genomics
Healthcare Data
AI
Data Science
SQL
Python

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI